These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35159298)

  • 1. Clinical Heterogeneity in
    Capiau S; Smet J; De Paepe B; Yildiz Y; Arslan M; Stevens O; Verschoore M; Stepman H; Seneca S; Vanlander A
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MT-ATP6 mitochondrial disease variants: Phenotypic and biochemical features analysis in 218 published cases and cohort of 14 new cases.
    Ganetzky RD; Stendel C; McCormick EM; Zolkipli-Cunningham Z; Goldstein AC; Klopstock T; Falk MJ
    Hum Mutat; 2019 May; 40(5):499-515. PubMed ID: 30763462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel MT-ATP6 variant associated with complicated ataxia in two unrelated Italian patients: case report and functional studies.
    Sala D; Marchet S; Nanetti L; Legati A; Mariotti C; Lamantea E; Ghezzi D; Catania A; Lamperti C
    Orphanet J Rare Dis; 2024 May; 19(1):200. PubMed ID: 38755691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation m.8561C>G in MT-ATP6/8 causing a mitochondrial syndrome with ataxia, peripheral neuropathy, diabetes mellitus, and hypergonadotropic hypogonadism.
    Kytövuori L; Lipponen J; Rusanen H; Komulainen T; Martikainen MH; Majamaa K
    J Neurol; 2016 Nov; 263(11):2188-2195. PubMed ID: 27502083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mitochondrial ATP6 frameshift mutation causing isolated complex V deficiency, ataxia and encephalomyopathy.
    Jackson CB; Hahn D; Schröter B; Richter U; Battersby BJ; Schmitt-Mechelke T; Marttinen P; Nuoffer JM; Schaller A
    Eur J Med Genet; 2017 Jun; 60(6):345-351. PubMed ID: 28412374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease.
    Pitceathly RD; Murphy SM; Cottenie E; Chalasani A; Sweeney MG; Woodward C; Mudanohwo EE; Hargreaves I; Heales S; Land J; Holton JL; Houlden H; Blake J; Champion M; Flinter F; Robb SA; Page R; Rose M; Palace J; Crowe C; Longman C; Lunn MP; Rahman S; Reilly MM; Hanna MG
    Neurology; 2012 Sep; 79(11):1145-54. PubMed ID: 22933740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants in Human ATP Synthase Mitochondrial Genes: Biochemical Dysfunctions, Associated Diseases, and Therapies.
    Del Dotto V; Musiani F; Baracca A; Solaini G
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype analysis of MT-ATP6-associated Leigh syndrome.
    Na JH; Lee YM
    Acta Neurol Scand; 2022 Apr; 145(4):414-422. PubMed ID: 34877647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel insights into the functional metabolic impact of an apparent de novo m.8993T>G variant in the MT-ATP6 gene associated with maternally inherited form of Leigh Syndrome.
    Uittenbogaard M; Brantner CA; Fang Z; Wong LC; Gropman A; Chiaramello A
    Mol Genet Metab; 2018 May; 124(1):71-81. PubMed ID: 29602698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Episodic weakness due to mitochondrial DNA MT-ATP6/8 mutations.
    Auré K; Dubourg O; Jardel C; Clarysse L; Sternberg D; Fournier E; Laforêt P; Streichenberger N; Petiot P; Gervais-Bernard H; Vial C; Bedat-Millet AL; Drouin-Garraud V; Bouillaud F; Vandier C; Fontaine B; Lombès A
    Neurology; 2013 Nov; 81(21):1810-8. PubMed ID: 24153443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MT-ATP6 mitochondrial disease identified by newborn screening reveals a distinct biochemical phenotype.
    Tise CG; Verscaj CP; Mendelsohn BA; Woods J; Lee CU; Enns GM; Stander Z; Hall PL; Cowan TM; Cusmano-Ozog KP
    Am J Med Genet A; 2023 Jun; 191(6):1492-1501. PubMed ID: 36883293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the clinical phenotypes of MT-ATP6 mutations.
    López-Gallardo E; Emperador S; Solano A; Llobet L; Martín-Navarro A; López-Pérez MJ; Briones P; Pineda M; Artuch R; Barraquer E; Jericó I; Ruiz-Pesini E; Montoya J
    Hum Mol Genet; 2014 Dec; 23(23):6191-200. PubMed ID: 24986921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homoplasmic deleterious MT-ATP6/8 mutations in adult patients.
    Rucheton B; Jardel C; Filaut S; Amador MDM; Maisonobe T; Serre I; Romero NB; Leonard-Louis S; Haraux F; Lombès A
    Mitochondrion; 2020 Nov; 55():64-77. PubMed ID: 32858252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mitochondrial DNA variant m.9032T > C in MT-ATP6 encoding p.(Leu169Pro) causes a complex mitochondrial neurological syndrome.
    Knight KM; Shelkowitz E; Larson AA; Mirsky DM; Wang Y; Chen T; Wong LJ; Friederich MW; Van Hove JLK
    Mitochondrion; 2020 Nov; 55():8-13. PubMed ID: 32931937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Threshold of heteroplasmic truncating MT-ATP6 mutation in reprogramming, Notch hyperactivation and motor neuron metabolism.
    Kenvin S; Torregrosa-Muñumer R; Reidelbach M; Pennonen J; Turkia JJ; Rannila E; Kvist J; Sainio MT; Huber N; Herukka SK; Haapasalo A; Auranen M; Trokovic R; Sharma V; Ylikallio E; Tyynismaa H
    Hum Mol Genet; 2022 Mar; 31(6):958-974. PubMed ID: 34635923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic variants in MT-ATP6: A United Kingdom-based mitochondrial disease cohort study.
    Ng YS; Martikainen MH; Gorman GS; Blain A; Bugiardini E; Bunting A; Schaefer AM; Alston CL; Blakely EL; Sharma S; Hughes I; Lim A; de Goede C; McEntagart M; Spinty S; Horrocks I; Roberts M; Woodward CE; Chinnery PF; Horvath R; Nesbitt V; Fratter C; Poulton J; Hanna MG; Pitceathly RDS; Taylor RW; Turnbull DM; McFarland R
    Ann Neurol; 2019 Aug; 86(2):310-315. PubMed ID: 31187502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in MT-ATP6 are a frequent cause of adult-onset spinocerebellar ataxia.
    Nolte D; Kang JS; Hofmann A; Schwaab E; Krämer HH; Müller U
    J Neurol; 2021 Dec; 268(12):4866-4873. PubMed ID: 34037856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co segregation of the m.1555A>G mutation in the MT-RNR1 gene and mutations in MT-ATP6 gene in a family with dilated mitochondrial cardiomyopathy and hearing loss: A whole mitochondrial genome screening.
    Alila-Fersi O; Chamkha I; Majdoub I; Gargouri L; Mkaouar-Rebai E; Tabebi M; Tlili A; Keskes L; Mahfoudh A; Fakhfakh F
    Biochem Biophys Res Commun; 2017 Feb; 484(1):71-78. PubMed ID: 28104394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of structure and function of ATP synthase and cytochrome c oxidase by lack of Fo-a and Cox3 subunits caused by mitochondrial DNA 9205delTA mutation.
    Hejzlarová K; Kaplanová V; Nůsková H; Kovářová N; Ješina P; Drahota Z; Mráček T; Seneca S; Houštěk J
    Biochem J; 2015 Mar; 466(3):601-11. PubMed ID: 25588698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a human mitochondrial oligonucleotide microarray (h-MitoArray) and gene expression analysis of fibroblast cell lines from 13 patients with isolated F1Fo ATP synthase deficiency.
    Cízková A; Stránecký V; Ivánek R; Hartmannová H; Nosková L; Piherová L; Tesarová M; Hansíková H; Honzík T; Zeman J; Divina P; Potocká A; Paul J; Sperl W; Mayr JA; Seneca S; Houstĕk J; Kmoch S
    BMC Genomics; 2008 Jan; 9():38. PubMed ID: 18221507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.